Revolution Medicines, Inc. (RVMD) stock
RVMDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as RVMDW
$159.82−2.87 (-1.76%)
Close on Nov 18, 2026Market cap $34.26BP/E –Yield –
Revolution Medicines pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
No pe ratio figures for Revolution Medicines
Revolution Medicines has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?